Clinical Trials on Ckd-Mbd in Poland

Total 68 results

Medical University of Silesia

Recruiting

CBD (Cannabidiol) Intraoral Application and TMD (Temporomandibular Disorders)

Bruxism | Myofascial Pain | Temporomandibular Disorder | CBD | Orofacial Pain

Poland
Medical University of Silesia

Unknown

Methodology for Developing an Occlusal Appliance With CBD Active Carrier (CBD-OCC-APP)

Cannabis | Myofascial Pain | Temporomandibular Disorder | CBD | Electromyography | Occlusal Appliance

Poland
Baxter Healthcare Corporation

Enrolling by invitation

A Post-Market Clinical Performance and Safety Evaluation of GamCath HighFlow Dolphin Protect Catheter

ESRD | Acute Renal Failure | CKD | AKI - Acute Kidney Injury

Poland
Leiden University Medical Center
Maasstad Hospital; Alrijne Hospital

Recruiting

Prediction of IBD Disease Activity in Individual Patients Based on PROMs and Clinical Data (PrePro)

IBD | Inflammatory Bone Disease

Netherlands
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD

Pediatric Hypertension With or Without CKD

Belgium, Poland, Italy, Germany, Guatemala, France, Hungary, Brazil, Lithuania
Medical University of Lodz
Baxter Healthcare Corporation

Unknown

Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft Surgery (Hemopatch)

CHD - Coronary Heart Disease

Poland
Academisch Medisch Centrum - Universiteit van Amsterdam...

Recruiting

Comparing a Diagnostic and Treatment Strategy of Upfront CTCA With SOC in Patients With Chest Pain and Suspected CAD (CLEAR-CAD)

Chest Pain | CAD

Netherlands
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

Chronic Kidney Disease (CKD)

United States, Puerto Rico
H. Lundbeck A/S

Completed

Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD) (RECONNECT)

Anxiety Disorders | MDD

Estonia, France, Italy, Korea, Republic of, Poland, Spain
Allergan

Completed

A Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula

Age-related Volume Deficit in the Mid-face

United States
AstraZeneca

Terminated

Open-label Extension Study of Brazikumab in Crohn's Disease (INTREPID OLE)

Crohn's Disease | IBD

United States, Taiwan, Poland, Germany, South Africa
Amgen

Completed

Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis (ADAPTATION)

Anaemia | Chronic Kidney Disease (CKD)

Austria, Hungary, Spain, Bulgaria, Poland, Greece, Czech Republic, Italy
Brigham and Women's Hospital

Completed

Study of Perfusion and Anatomy's Role in Coronary Artery (CAD) (SPARC)

Known CAD, or Intermediate-high Pretest Likelihood for CAD

United States, Canada
Erasmus Medical Center

Enrolling by invitation

Explorative Study to Investigate the Acid-base Response to Sodium and Potassium Salts in Patients With Chronic Kidney Disease. (5S)

CKD | Electrolyte and Fluid Balance Conditions | Metabolic Acidosis

Netherlands
GlaxoSmithKline

Completed

Effects of Antidepressants on Sexual Functioning

Major Depressive Disorder (MDD)

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment

MDD

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy

Major Depressive Disorder (MDD)

United States
GlaxoSmithKline

Completed

Sexual Functioning Study With Antidepressants

Depressive Disorder, Major | Major Depressive Disorder (MDD)

United States
Sandoz

Completed

Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa (ACCESS)

Anemia | Chronic Kidney Disease (CKD)

United States
Takeda

Active, not recruiting

A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland (VARIETY)

Crohn's Disease | Ulcerative Colitis | Inflammatory Bowel Disease (IBD)

Poland
Neurolief Ltd.

Active, not recruiting

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD) (MDD)

MDD

United States, Israel
Novartis Pharmaceuticals

Completed

Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM) (TRANSFORM)

Hemodialysis | Renal Replacement Therapy | End Stage Renal Disease (ESRD) | Renal Transplantation | Chronic Kidney Disease (CKD)

Germany, United States, Belgium, Italy, Spain, Croatia, Taiwan, Australia, Austria, Greece, Korea, Republic of, Lebanon, Czechia, Israel, Netherlands, Slovenia, Switzerland, Thailand, Norway, Turkey, Sweden, Argentina, Brazil, Japan, Se... and more
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

United States, Spain, Hungary, South Africa, Croatia, France, Poland, India, Canada, Sweden, Malaysia
AstraZeneca

Recruiting

Observational Secondary Data Study Describing Treatment With Dapagliflozin Among Adult Chronic Kidney Disease Patients (OPTIMISE-CKD)

Chronic Kidney Disease (CKD)

Hungary, Romania, Poland, Bulgaria, Croatia, Slovenia
Assurex Health Inc.
University of Michigan

Completed

Genomics Used to Improve DEpression Decisions (GUIDED)

Major Depressive Disorder (MDD)

United States
AstraZeneca
Targacept Inc.

Completed

A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Depression | Major Depressive Disorder | MDD

United States, Puerto Rico
Astellas Pharma Inc

Completed

A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)

Coronary Artery Disease (CAD)

United States
AstraZeneca

Terminated

An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease (INTREPID)

Crohn's Disease | IBD

United States, Italy, Taiwan, Korea, Republic of, Spain, Germany, Poland, Russian Federation, Israel, Ukraine, Canada, Czechia, South Africa, United Kingdom, Hungary, India, Slovakia
Astellas Pharma Europe Ltd.

Completed

Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI) (PROFILE)

Inflammatory Bowel Disease (IBD) | Clostridium Difficile Infection (CDI)

Austria, France, Greece, Italy, Poland, Russian Federation, United Kingdom
Ironwood Pharmaceuticals, Inc.
Medpace, Inc.

Terminated

A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment

Gout | Chronic Kidney Disease (CKD)

United States, Hungary, Poland, Czechia
Novartis

Completed

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

Major Depressive Disorder (MDD)

United States
GlaxoSmithKline

Completed

Lethargic Depression Study

Epilepsy | Major Depressive Disorder (MDD)

United States
Harvard Pilgrim Health Care
Brigham and Women's Hospital; University of California, Irvine; University of... and other collaborators

Active, not recruiting

INSPIRE Trial for Abdominal Infections

Abdominal (ABD) Infection

United States
Abbott
Massachusetts General Hospital; Harvard University

Terminated

The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5 (PRIMO II)

Hypertrophy, Left Ventricular | Chronic Kidney Disease (CKD) Stage 5

Italy, United States, Taiwan, Poland, United Kingdom, Greece, Germany, Russian Federation, Spain, Australia, Czech Republic, Puerto Rico, Romania
Epix Pharmaceuticals, Inc.

Completed

A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder

Major Depressive Disorder (MDD)

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)

Crohn's Disease | Colitis | Inflammatory Bowel Disease | IBD

United States, France, Poland, United Kingdom, Germany, Spain, Israel, Bulgaria, Serbia, South Africa, Japan, Canada, Australia, Netherlands, Korea, Republic of, Belgium, New Zealand, Brazil, Russian Federation, Austria, Hungary, ... and more
GlaxoSmithKline

Completed

An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder

Major Depressive Disorder (MDD)

United States
MSI Methylation Sciences, Inc.

Completed

Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

United States
GlaxoSmithKline

Completed

Study Of GW679769 In Major Depressive Disorder

Depressive Disorder, Major | Major Depressive Disorder (MDD)

United States, Canada
GlaxoSmithKline

Completed

Depression Study In Elderly Patients

Depressive Disorder, Major | Major Depressive Disorder (MDD)

United States
Bayer

Completed

A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease (ARRIVE)

Moderate Risk of CVD

Poland, United States, Italy, United Kingdom, Germany, Spain, Puerto Rico, Ireland
Eli Lilly and Company
Daiichi Sankyo Co., Ltd.

Terminated

Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI) (TRIGGER-PCI)

Coronary Artery Disease (CAD)

United States, Germany
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)

Crohn's Disease | Colitis | Inflammatory Bowel Disease | IBD

United States, France, Poland, United Kingdom, Germany, Spain, Israel, Bulgaria, Serbia, South Africa, Japan, Australia, Canada, Netherlands, Korea, Republic of, New Zealand, Brazil, Russian Federation, Belgium, Hungary, Croatia, ...
Puma Biotechnology, Inc.

Completed

A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting (NALA)

HER2+ Metastatic Breast Cancer (MBC)

United States, Canada, Spain, Singapore, Korea, Republic of, Taiwan, United Kingdom, Israel, Australia, Japan, Hong Kong, Finland, Ireland, Italy, France, Portugal, Germany, Sweden, Belgium, Brazil, Czechia, Switzerland, Argentina, Au... and more
AstraZeneca

Completed

A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD

Type 2 Diabetes Mellitus, CKD and Albuminuria

United States, Spain, Canada, Korea, Republic of, Mexico, Japan, Taiwan, Australia, South Africa
Alexion Pharmaceuticals, Inc.

Recruiting

ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE (ARTEMIS)

Chronic Kidney Disease | CKD | Cardiopulmonary Bypass | Cardiac Disease

United States, China, United Kingdom, Germany, Italy, Korea, Republic of, Netherlands, Spain, Japan, Brazil, India, Taiwan, Australia, Canada, Israel, Hong Kong, Poland, Argentina, Turkey
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

Finland, Germany, Korea, Republic of, United States, Taiwan, Estonia, India, Italy, Mexico
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

Crohn's Disease | Colitis | Inflammatory Bowel Disease | IBD

United States, France, Poland, United Kingdom, Germany, Spain, Serbia, South Africa, Japan, Israel, Canada, Australia, Netherlands, Korea, Republic of, Belgium, New Zealand, Brazil, Austria, Ireland, Czech Republic, Hungary, Denmark, Icela...
AstraZeneca

Terminated

Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis (Expedition)

Ulcerative Colitis | IBD

United States, Italy, Taiwan, Korea, Republic of, Germany, Spain, Russian Federation, Japan, South Africa, Hungary, Poland, Israel, Puerto Rico, Czechia, Ukraine, United Kingdom, Canada, India, Slovakia
Astellas Pharma Global Development, Inc.

Completed

A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT) (EXERRT)

Coronary Artery Disease (CAD)

United States, Peru, Argentina, Puerto Rico

Clinical Trials on Ckd-Mbd in Poland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations